News Tagged ‘Janssen-Ortho’

Canadian groups issue label change on birth control patch

Canadian pharmaceutical company Janssen-Ortho, Inc. in cooperation with Health Canada has issued a press release updating information on the average daily release rates of contraceptive hormones from the Transdermal Contraceptive System () that is marketed in Canada and approved for use for the prevention of pregnancy. is bioequivalent to Ortho Evra, the birth control that is marketed in the United States.

Read the rest of this entry »